Jazz Pharmaceuticals (FRA:J7Z) Days Sales Outstanding : 71.35 (As of Mar. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Jazz Pharmaceuticals Days Sales Outstanding?

Jazz Pharmaceuticals's average Accounts Receivable for the three months ended in Mar. 2024 was €649 Mil. Jazz Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was €830 Mil. Hence, Jazz Pharmaceuticals's Days Sales Outstanding for the three months ended in Mar. 2024 was 71.35.

The historical rank and industry rank for Jazz Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

FRA:J7Z' s Days Sales Outstanding Range Over the Past 10 Years
Min: 47.1 Med: 54.51 Max: 64.6
Current: 62.21

During the past 13 years, Jazz Pharmaceuticals's highest Days Sales Outstanding was 64.60. The lowest was 47.10. And the median was 54.51.

FRA:J7Z's Days Sales Outstanding is ranked better than
57.96% of 892 companies
in the Biotechnology industry
Industry Median: 72.19 vs FRA:J7Z: 62.21

Jazz Pharmaceuticals's Days Sales Outstanding increased from Mar. 2023 (65.53) to Mar. 2024 (71.35).

Jazz Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Jazz Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jazz Pharmaceuticals Days Sales Outstanding Chart

Jazz Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

51.81

60.71

54.95

58.83

65.52

Jazz Pharmaceuticals Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															65.53	59.18	57.69	60.75	71.35

Competitive Comparison of Jazz Pharmaceuticals's Days Sales Outstanding

For the Biotechnology subindustry, Jazz Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Jazz Pharmaceuticals's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Jazz Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Jazz Pharmaceuticals's Days Sales Outstanding falls into.

Jazz Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Jazz Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (615.009	+	647.213)	/	2 )	/	3515.965	*	365
=	631.111					/	3515.965	*	365
=	65.52

Jazz Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (647.213	+	650.527)	/	2 )	/	829.824	*	365 / 4
=	648.87					/	829.824	*	365 / 4
=	71.35

Jazz Pharmaceuticals (FRA:J7Z) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Jazz Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Jazz Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Jazz Pharmaceuticals (FRA:J7Z) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Jazz Pharmaceuticals PLC (FRA:J7Z) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

JAZZ:USA JAZZ:Mexico

Address

Waterloo Road, Fifth Floor, Waterloo Exchange, Dublin, IRL, D04 E5W7

Website

https://www.jazzpharmaceuticals.com

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Jazz Pharmaceuticals (FRA:J7Z) Headlines

No Headlines